ANOVA	Analysis of variance
AQbD	Analytical Quality by Design
ASD	Asymmetric screening design
BBD	Box-Behnken design
BGE	background electrolyte
CCC	Central composite circumscribed design
CCD	Central composite design
CD	cyclodextrin
CE	capillary electrophoresis
CEC	capillary electrochromatography
CE-MS	capillary electrophoresis—mass spectrometry
CE-ESI-MS	capillary electrophoresis coupled with electrospray ionization mass spectrometry
CMA	Critical Method Attribute
CMP	Critical Method Parameter
CM-β-CD	carboxymethyl-β-cyclodextrin
CPP	critical process parameter
CQA	critical quality attributes
CS	chiral selector
CSP	chiral stationary phase
CZE	capillary zone electrophoresis
D-oD	D-optimal design
D-Phe	D-Phenylalanine
DoE	Design of Experiments
DD	Doehlert design
DM-β-CD	dimethyl-β-cyclodextrin
DS	Design Space
EMA	European Medicines Agency
EOF	electroosmotic flow
FDA	Food and Drug Administration
FCCD	Face centered central composite design
FFD	Full factorial design
FLEC	l-(9-fluorenyl)ethyl chloroformate
FMOC	9-fluorenylmethyl chloroformate
FrFD	Fractional factorial design
HDAS-β-CD	heptakis(2,3-di-O-acetyl-6-O-sulfo)-β-cyclodextrin
HDM-β-CD	heptakis-2,6-di-O-methyl-β-cyclodextrin
HDMS-β-CD	heptakis-(2,3-di-O-methyl-6-O-sulfo)-β-cyclodextrin
HES-β-CD	heptakis-6-sulfato-β-CD
HMAS-β-CD	heptakis(2-O-methyl-3-O-acetyl-6-O-sulfo)-β-cyclodextrin
HPLC	high performance liquid chromatography
HP-β-CD	hydroxypropyl-β-cyclodextrin
HP-γ-CD	hydroxypropyl-γ-cyclodextrin
HS-β-CD	highly sulphated-β-cyclodextrin
HTM-β-CD	heptakis (2,3,6-tri-O-methyl)-β-cyclodextrin
HSA	human serum albumin
ICH	International Council for Harmonisation
LIF	laser induced fluorescence
LOD	limit of detection
LOQ	limit of quantification
M-α-CD	methyl-α-cyclodextrin
M-β-CD	methyl-β-cyclodextrin
M-γ-CD	randomly methylated γ-cyclodextrin
MDA	3,4-methylenedioxyamphetamine
MDEA	3,4-methylenedioxyethylamphetamine
MDMA	3,4-methylenedioxymethamphetamine
MEKC	micellar electrokinetic chromatography
MODR	Method operable design region
NACE	nonaqueous capillary electrophoresis
OAD	Orthogonal array design
ODMS-γ-CD	octakis(2,3-di-O-methyl-6-O-sulfo)-γ-cyclodextrin
OFAT	one factor at a time
PBD	Plackett-Burman design
PEG	polyethylene glycol
PO	polar organic
QbD	Quality by Design
RP	reverse phase
RSM	Response Surface Methodology
S-β-CD	sulfated-β-CD
S-γ-CD	sulfated-γ-CD
SBE-β-CD	sulfobutylether-β-cyclodextrin
SDS	sodium dodecyl sulfate
S/N	signal-to-noise
SSD	Symmetric screening design
SNRI	serotonin and norepinephrine reuptake inhibitor
SSRI	selective serotonin reuptake inhibitor